{"id":474,"date":"2026-06-16T23:34:46","date_gmt":"2026-06-16T23:34:46","guid":{"rendered":"https:\/\/northcarolinamovingjournal.com\/?p=474"},"modified":"2026-06-16T23:34:46","modified_gmt":"2026-06-16T23:34:46","slug":"nc-lawmakers-seek-5-million-to-study-psychedelic-medicines","status":"publish","type":"post","link":"https:\/\/northcarolinamovingjournal.com\/?p=474","title":{"rendered":"NC lawmakers seek $5 million to study psychedelic medicines"},"content":{"rendered":"
\n

Long before Rep. Allen Chesser (R-Nash) was a member of the North Carolina House of Representatives, he was a member of the U.S. Army National Guard. He completed over 100 combat missions in Iraq as a turret gunner.<\/p>\n

Read more Anti-tethering bill for companion animals advances in NC House, but its future is uncertain<\/a><\/p>\n

\u201cI was fortunate enough to make it home, but many of us didn\u2019t make it home. And even those of us that did make it home still fight battles on a daily basis, and unfortunately, some of us are still losing those battles,\u201d said Chesser.<\/p>\n

Chesser said the country loses between 17 and 44 veterans to suicide every single day, which underscores the need for newer, better interventions for mental health. He believes psychedelic drugs could help.<\/p>\n

Senate Bill 1018, which has bipartisan backing, would establish a Breakthrough Therapies research grant fund and appropriate $5.4 million to study psychedelic medicines to treat military veterans, first responders and other trauma-impacted populations.<\/p>\n

\u201cPsychedelic-assisted therapy, chemical compounds like MDMA for PTSD, and psilocybin for treatment-resistant depression have shown in clinical trials results that traditional medicines cannot match,\u201d Chesser told reporters during a Tuesday press conference.<\/p>\n

Sen. Bob Brinson (R-Beaufort), a U.S. Army veteran, is a primary sponsor of the bill in the Senate. Brinson said momentum is building at the federal level to cut through the red tape and speed up research, review and access to breakthrough therapies.<\/p>\n

President Donald Trump in April signed an executive order for the Food and Drug Administration (FDA) to fast-track the review of psychedelic medicines for severe cases of depression and anxiety.<\/p>\n

\u201cWe know not every veteran is broken. But we also know that for veterans who do need help, no single treatment works for everyone,\u201d Brinson said. \u201cI believe scientifically proven medical treatment should be an all-of-the above opportunity for those who need them.\u201d<\/p>\n

Read more Special ed, civil rights to be shifted out of Trump\u2019s shrinking Department of Education<\/a><\/p>\n

Sen. Sophia Chitlik (D-Durham) signed onto the bill when a combat Marine with persistent PTSD in her own district told her he had to leave the country to get access to breakthrough therapies.<\/p>\n

\u201cStudy after study, including from our own NIH, have shown that psychedelics can yield durable, measurable results for treating trauma and depression,\u201d said Chitlik. \u201cI watched for years these incredible scientific developments scale. In some cases, just two to three supervised sessions of MDMA have effectively cured PTSD.\u201d<\/p>\n

With 600,000 veterans living in North Carolina, Chitlik said it makes sense for the state to play a leading role in advancing innovative treatments when the \u201cinevitable reclassification of psychedelics\u201d occurs at the federal level.<\/p>\n

Gina Giorgio, founder of the advocacy group Carolinas for Care, said the FDA has already designated seven psychedelic medicines as breakthrough therapies and more than 30 states are advancing legislation to be ready.<\/p>\n

\n

Beyond medical marijuana, a bipartisan group of NC legislators wants to study psychedelics<\/p>\n<\/blockquote>\n